IFITM1 and breast carcinoma: We should note that the ability of E2 to induce cell death in AI-resistant breast cancer cells has previously been reported by our laboratory [11,15,16]; however, this is the first study to show that suppression of IFITM1 enhances E2-induced cell death in AI resistant breast cancer cells.